ADIPOQ and neoplasm: Furthermore, adiponectin reduces the discharge of pro-inflammatory factors (e.g., IL-6 and Monocyte Chemoattractant Protein-1 (MCP-1)) by inhibiting the NF-κB pathway, thereby blocking M2 polarization of TAMs and maintaining an anti-tumor immune microenvironment (221).